Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Link
http://academic.oup.com/carcin/article-pdf/31/7/1284/17288969/bgq059.pdf
Reference43 articles.
1. Thyroid carcinoma;Gillenwater;Cancer Treat. Res.,1997
2. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments];Hundahl;Cancer,1998
3. Prospective multicenter study of thyroidcarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group;Sherman;Cancer,1998
4. [Papillary and follicular cancers of the thyroid];Schlumberger;Presse Med.,1998
5. The treatment of thyroid cancer;Fitzgibbons;Am. Surg.,2008
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preclinical evaluation of pharmacological inhibition of SIRT1 on the growth of tumoral and metastatic granulosa cells;2024-07-04
2. TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors;PLOS ONE;2024-04-03
3. Study on the Targeted Drugs for the Treatment of Thyroid Cancer Based on Network Pharmacology;Advances in Clinical Medicine;2024
4. Evaluating new treatments for anaplastic thyroid cancer;Expert Review of Anticancer Therapy;2022-11-02
5. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway;BioMed Research International;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3